Long Island Jewish Medical Center CLL Research and Treatment Program is a clinical research site located in New Hyde Park, New York, United States 11042.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Long Island Jewish Medical Center CLL Research and Treatment Program has participated in 1 clinical trials.
Therapeutic areas: Relapsed or Refractory Chronic Lymphocytic Leukemia.
Sponsors: Celgene.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Long Island Jewish Medical Center CLL Research and Treatment Program has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Long Island Jewish Medical Center CLL Research and Treatment Program has 1 clinical trials on record. Their work covers Relapsed or Refractory Chronic Lymphocytic Leukemia.
Long Island Jewish Medical Center CLL Research and Treatment Program has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.